Treasury Chief Reeves Intends Focused Action on Bills in Upcoming Budget
Treasury head Reeves has announced she is planning "targeted measures to address household expense pressures" in the forthcoming financial statement.
In comments to the BBC, she noted that reducing price rises is a joint duty of both the government and the central bank.
The UK's price growth is expected to be the most elevated among the Group of Seven developed nations this year and next.
Possible Energy Cost Measures
Sources suggest the government could take action to bring down energy bills, such as by cutting the current 5% level of value-added tax applied on energy supplies.
Another approach is to cut some of the government charges presently included in bills.
Budgetary Constraints and Expert Expectations
The administration will receive the next report from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much room there is for such measures.
The expectation from most analysts is that the Chancellor will have to announce tax rises or budget cuts in order to adhere to her voluntary fiscal targets.
Previously on the same day, analysis indicated there was a £22 billion gap for the Treasury chief to resolve, which is at the lower end of expectations.
"There's a joint job between the central bank and the government to further reduce some of the causes of price increases," Reeves stated to reporters in Washington, at the conferences of the International Monetary Fund and global financial institution.
Tax Commitments and International Concerns
While a great deal of the attention has been on probable tax increases, the chancellor said the most recent data from the OBR had not altered her commitment to campaign commitments not to raise rates on income tax, sales tax or National Insurance.
She blamed an "unpredictable global environment" with rising international and commercial issues for the Budget revenue measures, likely to be focused on those "with the broadest shoulders."
Global Economic Tensions
Referring to concerns about the UK's commercial links with China she said: "Our national security always come first."
Last week's announcement by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are key for advanced tech manufacturing led American leader the US President to threaten an additional 100% tariff on imports from China, raising the risk of an all-out commercial conflict between the two economic giants.
The American finance chief labeled China's decision "commercial pressure" and "a global supply chain power grab."
Questioned on accepting the American proposal to join its conflict with the Asian nation, Reeves said she was "very concerned" by Chinese measures and called on the Chinese government "to avoid restrictions and restrict access."
She said the decision was "harmful for the global economy and causes further obstacles."
"I believe there are areas where we must confront Chinese policies, but there are also important chances to trade with China's economy, including banking sector and other areas of the economic system. We've got to get that equilibrium appropriate."
The chancellor also confirmed she was cooperating with international partners "on our own essential resources strategy, so that we are less reliant."
NHS Medicine Costs and Funding
Reeves also admitted that the cost the National Health Service spends on pharmaceuticals could go up as a consequence of ongoing negotiations with the US government and its drugs companies, in exchange for lower tariffs and investment.
Some of the biggest global pharmaceutical manufacturers have said lately that they are either halting or abandoning investments in the UK, with several blaming the modest returns they are obtaining.
Last month, the Science Minister said the cost the health service spends on drugs would must increase to prevent businesses and drug research funding departing from the United Kingdom.
Reeves told the BBC: "We have seen due to the pricing regime, that drug testing, innovative medicines have not been available in the UK in the manner that they are in other European countries."
"The objective is to guarantee that people receiving care from the National Health Service are able to obtain the top essential medicines in the globe. And so we are looking at these issues, and... aiming to secure increased funding into Britain."